Specify a stock or a cryptocurrency in the search bar to get a summary
Tela Bio Inc
TELATELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Address: 1 Great Valley Parkway, Malvern, PA, United States, 19355
Analytics
WallStreet Target Price
9.2 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures TELA
Dividend Analytics TELA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TELA
Stock Valuation TELA
Financials TELA
Results | 2019 | Dynamics |